These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 26281190

  • 1. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
    Vasilyeva MP, Rudenko TE, Kutyrina IM, Solomakhina NI.
    Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
    [Abstract] [Full Text] [Related]

  • 2. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S, Ichikawa K, Yamada K, Tanimoto M, Miki T, Otsuka H, Yamamoto K, Kawamoto K, Katayama Y, Tanakaya M, Ito H.
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Rudenko TE, Kamyshova ES, Vasilyeva MP, Bobkova IN, Solomakhina NI, Shvetsov MY.
    Ter Arkh; 2018 Sep 20; 90(9):60-67. PubMed ID: 30701737
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E, Mitsis M, Naka KK, Pappas C, Lakkas L, Harisis C, Pappas K, Koutlas V, Tzalavra I, Spanos G, Michalis LK, Siamopoulos KC.
    Transplant Proc; 2014 Nov 20; 46(9):3194-8. PubMed ID: 25420857
    [Abstract] [Full Text] [Related]

  • 7. Cystatin C and Cardiac Measures in Children and Adolescents With CKD.
    Brady TM, Townsend K, Schneider MF, Cox C, Kimball T, Madueme P, Warady B, Furth S, Mitsnefes M.
    Am J Kidney Dis; 2017 Feb 20; 69(2):247-256. PubMed ID: 27856090
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789
    [Abstract] [Full Text] [Related]

  • 11. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, Takagi M, Sato M, Nagahama L, Omote K, Hisada A, Horikoshi S, Tomino Y.
    J Nephrol; 2012 Jan 06; 25(5):794-801. PubMed ID: 22241636
    [Abstract] [Full Text] [Related]

  • 12. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
    Pluta A, Stróżecki P, Krintus M, Odrowąż-Sypniewska G, Manitius J.
    Ren Fail; 2015 Aug 05; 37(7):1105-10. PubMed ID: 26156686
    [Abstract] [Full Text] [Related]

  • 16. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE.
    Atherosclerosis; 2009 Dec 05; 207(2):546-51. PubMed ID: 19524924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?
    Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, Hosomi N, Yukiiri K, Noma T, Imai M, Kiyomoto H, Nishiyama A, Kohno M.
    Clin Exp Hypertens; 2010 Jan 05; 32(2):113-20. PubMed ID: 20374184
    [Abstract] [Full Text] [Related]

  • 19. Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China.
    Dai D, Chang Y, Chen Y, Yu S, Guo X, Sun Y.
    BMC Cardiovasc Disord; 2017 Jan 13; 17(1):24. PubMed ID: 28086799
    [Abstract] [Full Text] [Related]

  • 20. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
    Albayrak S, Ordu S, Ozhan H, Yazici M, Aydin M, Alemdar R, Kaya A.
    Blood Press; 2009 Jan 13; 18(4):187-91. PubMed ID: 19521888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.